A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case report

Hao Zeng, Yujie Liu, Weiya Wang, Yuan Tang, Panwen Tian, Weimin Li